What Is the Overall Sentiment on ATI Physical Therapy (ATIP) Shares?

This afternoon we watched ATI Physical Therapy drop -3.0% to a price of $9.9 per share. The small-cap Medical Care Facility company is now trading -31.72% below its average target price of $14.5. Analysts have set target prices ranging from $14.5 to $14.5 per share for ATI Physical Therapy, and have given the stock an average rating of hold.

The stock has an average amount of shares sold short at 5.6%, and a short ratio of 10.48. Insiders such as directors and executives own 9.18% of the company's shares, from which we can deduce there is a significant degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 89.6% of ATI Physical Therapy's shares being owned by this investor type.

Institutions Invested in ATI Physical Therapy

Date Reported Holder Percentage Shares Value
2023-03-31 Advent International Corporation 56% 115,830,656 $1,146,723,450
2023-03-31 Fortress Investment Group LLC 8% 16,025,000 $158,647,493
2023-03-31 Knighthead Capital Management, Llc 6% 12,929,880 $128,005,807
2023-03-31 GCM Grosvenor Holdings, LLC 2% 5,154,131 $51,025,894
2023-03-31 Blackrock Inc. 2% 4,556,988 $45,114,179
2023-03-31 Vanguard Group, Inc. (The) 2% 3,708,577 $36,714,910
2023-03-31 HighTower Advisors, LLC 1% 2,991,020 $29,611,096
2023-03-31 Northern Trust Corporation 1% 1,410,183 $13,960,811
2023-03-31 Geode Capital Management, LLC 1% 1,242,055 $12,296,344
2023-03-31 State Street Corporation 0% 1,011,807 $10,016,888

Besides an analyst consensus of strong upside potential, other market factors point to there being mixed market sentiment on ATI Physical Therapy.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS